Impact of biological therapy on cumulative corticosteroid dose reduction in patients with severe asthma.
D. Rodríguez Plaza (Barcelona (Barcelona), Spain), M. Vivas Roca (Barcelona (Barcelona), Spain), H. Cabrerizo Carreño (Barcelona (Barcelona), Spain), B. Gómez Martínez (Barcelona (Barcelona), Spain), S. Santos Pérez (Barcelona (Barcelona), Spain), M. Muñoz-Esquerre (Barcelona (Barcelona), Spain)
Source: International Congress 2022 – Studies targeting IL-5 pathways in asthma
Session: Studies targeting IL-5 pathways in asthma
Session type: Thematic Poster
Number: 2141
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Rodríguez Plaza (Barcelona (Barcelona), Spain), M. Vivas Roca (Barcelona (Barcelona), Spain), H. Cabrerizo Carreño (Barcelona (Barcelona), Spain), B. Gómez Martínez (Barcelona (Barcelona), Spain), S. Santos Pérez (Barcelona (Barcelona), Spain), M. Muñoz-Esquerre (Barcelona (Barcelona), Spain). Impact of biological therapy on cumulative corticosteroid dose reduction in patients with severe asthma.. 2141
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|